A study examining the relationship between SMAD-7 and TGF-β1 in patients with low-risk MDS found that inhibiting SMAD-7 expression using a lentivirus significantly increased TGF-β1 sensitivity [20]. The gene discussed is TGFB1; the disease is myelodysplastic syndrome.